Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
Cell Stem Cell - United States
doi 10.1016/j.stem.2018.10.005
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Elsevier BV